Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2004
Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrityOliver Jung, Markus Bickel, Tilmann Ditting, et al.
AIDS (London, England)|September 26, 2009
Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patientsGerd Fätkenheuer, Schlomo Staszewski, Andreas Plettenburg, et al.
Antiviral Therapy|December 3, 2008
Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapyAnna M Geretti, Colette Smith, Annette Haberl, et al.
Sexually Transmitted Diseases|June 10, 2010
Prevalence- and gender-specific immune response to opportunistic infections in HIV-infected patients in LesothoHolger F Rabenau, Tessa Lennemann, Claudia Kircher, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 2005
Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre studyHassane Izzedine, Jean Sebastien Hulot, Daniel Vittecoq, et al.
Antiviral Therapy|May 17, 2007
Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimenMartin Stürmer, Brenda Dauer, Manfred Moesch, et al.
The AIDS Reader|June 21, 2005
Effect of recombinant human growth hormone on exercise capacity in patients with HIV-associated wasting on HAARTWilliam J Evans, Donald P Kotler, Schlomo Staszewski, et al.
The Journal of Antimicrobial Chemotherapy|August 30, 2008
Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitorsNils von Hentig, Ann-Kristin Förster, Karina Kuczka, et al.
AIDS (London, England)|December 22, 2007
Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infectionKaren Tashima, Schlomo Staszewski, Mark Nelson, et al.
The Journal of Antimicrobial Chemotherapy|September 8, 2006
The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapySchlomo Staszewski, Errol Babacan, Christoph Stephan, et al.
Pageof 7